| Company Name | Pfizer |
|---|---|
| Protocol Number | A6181225 |
| Title of Study | The Observational Registry: Nationwide Data Collection on Gastrointestinal Stromal Tumors (GISTs) Patients |
| Primary Objective | 1. To explore real world experience of therapies for Taiwanese GIST 2. Prevalence of Taiwanese GIST 3. Dosage pattern of TKI therapies |
| Number of Sites | 10 |
| Period of Study | From：2018/03/01 to：2020/12/31 |
| Number of Patients | 3000人 |
| IRB Approval Date | 2018/07/31 |
| Publication Plan / Date | 2021/06/30 |
